Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CAMK1G SGC Tm panel (DSF)
Assay data:1 Tested
SummaryRelated BioAssays by Target
Thermal Shift Assay. Domain: start/stop: Q15-H316
Assay data:27 Tested
Inhibition of recombinant full length human CaMK1gamma assessed as residual activity at 1 uM using KKLRRTLSFAEPG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis relative to control
SummaryPubMed CitationRelated BioAssays by Target
CAMK1G DiscoveRx kinase panel
CaMKIgamma(h) Kinase panel
Inhibition of CAMK1G (unknown origin) at 1 uM
KinomeScan assay: inhibition of CAMK1G
Assay data:108 Tested
CaMK1gamma(CA1GLGN1) Takeda global kinase panel
Assay data:1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, activity ≤ 1 µMRelated BioAssays by Target
CaMKIgamma(h) Eurofins kinase panel
CaMKI?(h) Eurofins Kinase panel
CaMKIgamma(h) Millipore kinase panel
CAMK1G Invitrogen Lab (UK) kinase screen (BI)
Inhibition of human CAMK1G assessed as percent of control at 2000 nM by KINOMEscan assay relative to control
Inhibition of DNA-tagged human CAMK1G assessed as percent of control at 50000 nM by qPCR analysis relative to control
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on